SNY

Sanofi NASDAQ

Healthcare ·Drug Manufacturers - General ·FR · sanofi.com

$43.35

Mkt Cap $104.4B

52w Low $43.15 1.6% of range 52w High $55.29

50d MA $46.35 200d MA $48.03

P/E (TTM) 22.7x

EV/EBITDA 9.1x

P/B 1.6x

Debt/Equity 0.3x

ROE —

P/FCF 11.3x

RSI (14) —

ATR (14) —

Beta 0.32

50d MA $46.35

200d MA $48.03

Avg Volume 3.9M

About

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, ot…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 23, 2026	AMC	1.06	1.10	+3.8%	47.53	-0.3%	-1.6%	-3.4%	-3.3%	-3.2%	-2.0%	—
Jan 29, 2026	AMC	0.84	0.89	+6.0%	46.20	+1.5%	+1.8%	+2.3%	+2.8%	+4.1%	+2.8%	—
Oct 24, 2025	AMC	1.60	1.70	+6.2%	51.64	-0.5%	-0.4%	-1.1%	-1.9%	-1.4%	-2.1%	—
Jul 31, 2025	AMC	0.96	0.90	-6.2%	45.64	+0.7%	+2.4%	+5.3%	+4.8%	+1.2%	+3.9%	—
Apr 24, 2025	AMC	0.90	0.94	+4.4%	53.54	-1.3%	-2.3%	-1.5%	+0.3%	+2.6%	+1.0%	—
Jan 30, 2025	AMC	0.71	0.70	-1.4%	54.15	+0.0%	+0.4%	-1.5%	-1.2%	-1.2%	-2.4%	—
Oct 25, 2024	AMC	1.35	1.57	+16.3%	54.34	-0.3%	+0.0%	-0.9%	-1.6%	-2.7%	-2.0%	—
Jul 25, 2024	AMC	0.86	0.93	+8.1%	53.10	-0.8%	-1.3%	-1.9%	-2.7%	-2.4%	-2.7%	—
Apr 25, 2024	AMC	0.94	0.97	+3.2%	49.36	-1.1%	-0.5%	-0.5%	-0.3%	+1.4%	+0.2%	—
Feb 1, 2024	AMC	0.94	0.89	-5.3%	48.41	-0.8%	-2.4%	-3.0%	-2.8%	-3.1%	-3.8%	—
Oct 27, 2023	AMC	1.37	1.39	+1.5%	43.13	+2.9%	+4.0%	+4.9%	+7.4%	+7.8%	+6.2%	—
Jul 28, 2023	AMC	1.55	0.95	-38.7%	52.48	+2.3%	+1.7%	+1.1%	-1.9%	-2.9%	-1.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 16	UBS	Downgrade	Buy → Neutral	—	$47.47	$46.93	-1.1%	-1.9%	-3.6%	-2.7%	-2.0%	-0.6%
Jan 6	Barclays	Downgrade	Overweight → Equal Weight	—	$47.51	$48.13	+1.3%	+1.4%	+1.8%	+1.3%	+3.2%	+0.2%
Dec 9	Guggenheim	Downgrade	Buy → Neutral	—	$48.44	$48.15	-0.6%	-1.3%	-0.4%	+0.9%	+0.5%	-1.3%
Dec 8	JP Morgan	Downgrade	Overweight → Neutral	—	$49.53	$48.65	-1.8%	-2.2%	-3.4%	-2.6%	-1.4%	-1.7%
Sep 8	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$46.50	$46.61	+0.2%	+0.6%	+2.0%	+1.4%	+2.5%	+1.1%
Sep 2	Deutsche Bank	Upgrade	Hold → Buy	—	$49.48	$49.67	+0.4%	+0.2%	+0.8%	-8.4%	-6.0%	-5.4%
Aug 8	JP Morgan	Upgrade	Neutral → Overweight	—	$47.43	$46.89	-1.1%	-0.6%	-0.5%	+1.3%	+2.8%	+3.4%
Jul 26	Argus	Maintains	Buy → Buy	—	$53.10	$52.67	-0.8%	-1.3%	-1.9%	-2.7%	-2.4%	-2.7%
Mar 27	Argus	Maintains	Buy → Buy	—	$52.61	$53.00	+0.7%	+1.2%	+3.0%	+3.5%	+2.6%	+3.4%
Aug 12	Deutsche Bank	Upgrade	Sell → Hold	—	$43.42	$43.97	+1.3%	+2.2%	+0.9%	+3.2%	-2.9%	-5.1%
Sep 27	SVB Leerink	Upgrade	Market Perform → Outperform	—	$47.94	$48.30	+0.8%	+0.4%	-0.1%	+0.9%	+0.6%	-0.1%
Mar 11	Goldman Sachs	Upgrade	Neutral → Buy	—	$46.16	$45.21	-2.1%	-3.0%	-11.5%	-5.3%	-10.1%	-5.5%
Feb 19	Argus	Maintains	Buy → Buy	—	$51.14	$50.87	-0.5%	-0.8%	-0.8%	-0.6%	-2.5%	-4.2%
Jan 6	JP Morgan	Upgrade	Neutral → Overweight	—	$50.76	$50.87	+0.2%	+1.0%	-0.0%	+0.4%	+0.8%	+1.7%
Dec 6	Barclays	Downgrade	Equal Weight → Underweight	—	$46.08	$46.31	+0.5%	-0.1%	-1.7%	+4.4%	+6.4%	+7.4%
Sep 23	Guggenheim	Upgrade	Neutral → Buy	—	$46.46	$45.95	-1.1%	-0.5%	+0.4%	+0.1%	+0.4%	-0.4%
Nov 8	Argus	Maintains	Buy → Buy	—	$45.33	$45.18	-0.3%	-0.8%	+0.6%	-1.6%	-0.9%	-0.6%
Nov 1	Barclays	Upgrade	Underweight → Equal Weight	—	$44.72	$45.10	+0.8%	+0.9%	-1.3%	+0.1%	-0.2%	+1.4%
Sep 10	Bank of America	Upgrade	Neutral → Buy	—	$42.09	$42.74	+1.5%	+1.3%	+0.9%	+3.0%	+5.5%	+4.1%
Sep 10	BofA Securities	Upgrade	Neutral → Buy	—	$42.09	$42.74	+1.5%	+1.3%	+0.9%	+3.0%	+5.5%	+4.1%
Aug 24	Argus	Maintains	Buy → Buy	—	$43.07	$43.22	+0.3%	+1.2%	+1.0%	+1.2%	+1.9%	+1.0%
Aug 10	Citigroup	Upgrade	Neutral → Buy	—	$41.92	$42.36	+1.0%	-0.8%	-1.0%	-1.5%	-3.6%	-1.6%
Jan 23	Barclays	Downgrade	Equal Weight → Underweight	—	$43.20	$44.08	+2.0%	+1.2%	+3.1%	+4.1%	+5.9%	+4.9%
Nov 15	Barclays	Upgrade	Underweight → Equal Weight	—	$44.65	$44.47	-0.4%	+0.0%	+0.0%	-0.2%	-0.7%	+0.3%
Aug 30	HSBC	Upgrade	Reduce → Hold	—	$48.96	$48.44	-1.1%	-1.6%	-0.2%	+0.7%	-0.3%	+0.9%
May 12	Barclays	Upgrade	Equal Weight → Overweight	—	$39.56	$40.09	+1.3%	-0.8%	-1.0%	+0.4%	-0.3%	-0.3%
May 3	HSBC	Downgrade	Buy → Hold	—	$41.46	$41.38	-0.2%	-0.7%	-2.6%	-5.8%	-6.1%	-4.8%
Dec 10	Exane BNP Paribas	Downgrade	Neutral → Underperform	—	$42.24	$41.95	-0.7%	-0.9%	-0.9%	-1.7%	+1.7%	+3.3%
Dec 1	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$44.22	$44.51	+0.7%	-0.4%	-0.8%	-2.5%	-2.0%	-1.9%
Nov 9	Bernstein	Downgrade	Outperform → Market Perform	—	$46.60	$45.52	-2.3%	-2.5%	-3.5%	-3.3%	-6.4%	-7.7%
Nov 9	Bryan Garnier	Downgrade	Buy → Neutral	—	$46.60	$45.52	-2.3%	-2.5%	-3.5%	-3.3%	-6.4%	-7.7%
Mar 17	Leerink Swann	Upgrade	Market Perform → Outperform	—	$48.62	$48.71	+0.2%	+0.7%	+3.2%	+1.7%	+4.2%	+4.9%
Oct 29	Bank of America	Downgrade	Buy → Neutral	—	$48.07	$45.37	-5.6%	-5.9%	-4.9%	-3.8%	-4.8%	-5.4%
Oct 29	Barclays	Downgrade	Overweight → Equal Weight	—	$48.07	$45.37	-5.6%	-5.9%	-4.9%	-3.8%	-4.8%	-5.4%
Oct 29	Jefferies	Downgrade	Buy → Hold	—	$48.07	$45.37	-5.6%	-5.9%	-4.9%	-3.8%	-4.8%	-5.4%
Oct 29	BofA Securities	Downgrade	Buy → Neutral	—	$48.07	$45.37	-5.6%	-5.9%	-4.9%	-3.8%	-4.8%	-5.4%
Oct 29	Deutsche Bank	Downgrade	Buy → Hold	—	$48.07	$45.37	-5.6%	-5.9%	-4.9%	-3.8%	-4.8%	-5.4%
Oct 28	Deutsche Bank	Downgrade	Buy → Hold	—	$52.82	$48.22	-8.7%	-9.0%	-14.4%	-13.5%	-12.5%	-13.3%
Jan 23	Citigroup	Downgrade	Buy → Neutral	—	$51.53	$51.86	+0.6%	-1.4%	-4.5%	-4.3%	-4.1%	-5.1%
Jan 9	S&P Capital IQ	Downgrade	Buy → Hold	—	$51.08	$50.99	-0.2%	-0.5%	-0.5%	-2.1%	-0.6%	+0.1%
Jan 6	JP Morgan	Downgrade	Overweight → Neutral	—	$52.04	$52.07	+0.1%	-0.1%	-0.2%	-1.8%	-2.3%	-2.4%
Nov 18	Kepler Cheuvreux	Upgrade	Hold → Buy	—	$53.96	$54.40	+0.8%	+0.1%	-1.3%	-1.9%	-2.5%	-1.8%
Nov 15	Mirabaud	Upgrade	Neutral → Buy	—	$53.05	$53.64	+1.1%	+1.7%	+1.8%	+0.4%	-0.2%	-0.9%
Nov 15	Mirabaud Securities	Upgrade	Neutral → Buy	—	$53.05	$53.64	+1.1%	+1.7%	+1.8%	+0.4%	-0.2%	-0.9%
Oct 31	Natixis	Upgrade	Neutral → Buy	—	$52.81	$53.73	+1.7%	+1.3%	-0.2%	+0.1%	-0.1%	+1.1%
Oct 18	Leerink Swann	Downgrade	Outperform → Market Perform	—	$50.13	$49.94	-0.4%	+0.2%	+1.0%	+2.4%	+2.2%	+2.9%
Sep 16	Barclays	Upgrade	Equal Weight → Overweight	—	$47.96	$48.44	+1.0%	-0.0%	+2.7%	+5.1%	+6.0%	+6.4%
Aug 21	Cowen & Co.	Downgrade	Outperform → Market Perform	—	$51.75	$51.23	-1.0%	-3.0%	-2.9%	-2.4%	-1.8%	-4.3%
May 3	Banco Sabadell	Downgrade	Buy → Sell	—	$55.00	$55.32	+0.6%	+1.2%	-3.6%	-2.5%	-0.4%	-1.3%
Feb 8	Kepler Cheuvreux	Downgrade	Buy → Hold	—	$45.30	$45.53	+0.5%	+2.7%	+6.0%	+7.8%	+9.3%	+6.5%

Data updated apr 27, 2026 2:17am · Source: massive.com